These are top 10 stocks traded on the Robinhood UK platform in July
Stifel initiated coverage on Hinge Health Inc (NYSE:HNGE) with a buy rating on Monday, setting a price target of $48.00 for the virtual physical therapy provider. According to InvestingPro data, the company maintains robust financials with a "Good" overall health score and an impressive 79.46% gross profit margin.
The investment firm cited Hinge Health’s software platform that delivers musculoskeletal care virtually through mobile applications and messaging with licensed physical therapists and coaches as the foundation for its positive outlook. The stock has experienced recent volatility, declining 8.29% over the past week, though it maintains a relatively modest P/E ratio of 9.86. InvestingPro analysis suggests the stock is currently trading above its Fair Value.
Stifel highlighted the company’s value proposition of reducing healthcare costs for employers and health plans by eliminating convenience barriers to physical therapy access, improving patient compliance, and lowering clinical expenses for members with chronic conditions.
The research note pointed out that while Hinge Health primarily serves self-insured employers currently, it has begun expanding into fully-insured plans such as Medicare Advantage, representing potential growth opportunities.
According to Stifel, Hinge Health’s competitive advantages stem from its scale, technology automation capabilities, and established distribution channels through national health plans and pharmacy benefit managers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.